.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Chinese Patent Office
Argus Health
Baxter
US Army
Novartis
Chubb
McKesson
Fuji
Cerilliant

Generated: June 27, 2017

DrugPatentWatch Database Preview

Nadolol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nadolol and what is the scope of nadolol freedom to operate?

Nadolol
is the generic ingredient in two branded drugs marketed by Sandoz, Ivax Sub Teva Pharms, Amneal Pharms Co, Invagen Pharms, Us Worldmeds Llc, Teva Pharms, Mylan, and Orion Corp Orion, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for nadolol. Seventeen suppliers are listed for this compound.

Summary for Generic Name: nadolol

Tradenames:2
Patents:1
Applicants:8
NDAs:9
Drug Master File Entries: see list4
Suppliers / Packagers: see list17
Bulk Api Vendors: see list28
Clinical Trials: see list21
Patent Applications: see list5,893
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nadolol at DailyMed

Pharmacology for Ingredient: nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
NADOLOL
nadolol
TABLET;ORAL074501-002Nov 9, 1995ABRXNoNo► Subscribe► Subscribe
Mylan
NADOLOL
nadolol
TABLET;ORAL074172-002Oct 31, 1993ABRXNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
NADOLOL
nadolol
TABLET;ORAL074255-001Jan 24, 1996ABRXNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
NADOLOL
nadolol
TABLET;ORAL074229-002Aug 30, 1996ABRXNoNo► Subscribe► Subscribe
Amneal Pharms Co
NADOLOL
nadolol
TABLET;ORAL208832-003Jun 2, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 19823,982,021► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-002Approved Prior to Jan 1, 19823,982,021► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-005Oct 28, 19863,935,267► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 19823,935,267► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-004Approved Prior to Jan 1, 19823,982,021► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
US Department of Justice
Argus Health
Dow
Fish and Richardson
Johnson and Johnson
Federal Trade Commission
Covington
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot